main content start
Invokana (canagliflozin) is an oral medication in the SGLT-2 inhibitor class of drugs. It blocks glucose from being reabsorbed by the kidneys. Excess glucose is released in the urine. Invokana should be taken in the morning, and increased water intake throughout the day is recommended. Medications in the SGLT-2 inhibitor class may offer heart and kidney benefits for people with cardiovascular disease.
Invokana is approved for adults and children age 10 and over with type 2 diabetes.
- Invokana is used to improve blood glucose management in adults and children age 10 and over with type 2 diabetes. Invokana helps the kidneys of adults with type 2 diabetes get rid of glucose from the bloodstream to improve blood glucose management. It is not for treating type 1 diabetes.
- Invokana is taken once per day. It may be taken with or without food, but is usually taken in the morning with the first meal of the day.
- The usual initial dose of Invokana is 100 mg taken by mouth once a day in the morning. The dose may increase to 300 mg by mouth once a day for patients requiring additional glycemic management who are tolerating it well.
- Medications like Invokana may offer heart and kidney benefits for people with cardiovascular disease and type 2 diabetes.
- Common side effects may include increased urinary frequency, dizziness, and genital yeast infections.
Invokana Specs
Key specification
Generic Name
Canagliflozin
Approved for Kids
10+ with type 2 diabetes
Drug Class
SGLT-2 inhibitors
General Information
Product Name
Invokana
Product Type
Oral Medications
Brand
Janssen Pharmaceuticals
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
